Portfolio reports show the current active book. Closed and archived borrowers, including their history, are available in All Borrowers.
Portfolio Stress Test
LTM ending Q3 2026 · unadjusted financial analysis with retained covenant results shown separately
Unsaved analysis. Scenarios do not update financial statements, covenant actuals, approved marks or SBIC inputs.
Scenario Parameters
Unadjusted LTM financial analysis. Revenue and margin shocks apply to each of four consecutive quarters. EBITDA can become negative; NM means a ratio is not meaningful.
Rate changes apply once over one year to the shocked ending debt balance, assumed constant. A debt-only shock holds existing interest fixed; borrowing costs beyond the rate overlay are not estimated. For example, +100 bps on $20M adds $0.20M of annual interest; with +10% debt it adds $0.22M.
Retained covenant results are shown separately and remain unchanged. This scenario does not calculate contractual EBITDA, agreement-specific coverage, or new covenant breaches. Scenarios are not saved.
Analytical scenario results
Each pair shows baseline → scenario. Amounts are in $M. Incomplete histories stay visible.
| Company / source window | LTM EBITDA | Debt / LTM EBITDA | LTM interest coverage | LTM interest | Ending debt |
|---|---|---|---|---|---|
| BluePeak Healthcare Solutions Q4 2025 · Q1 2026 · Q2 2026 · Q3 2026 | $22.5M → $22.5M | 4.31x → 4.31x | 1.61x → 1.61x | $14.0M → $14.0M Rate overlay: $0.0M | $97.0M → $97.0M |
Retained covenant results — unchanged by this scenario
| Company | Covenant / basis | Retained tested actual | Threshold | Saved result |
|---|---|---|---|---|
| BluePeak Healthcare Solutions Q3 2026 | Total Leverage Supplied actual | 4.31x | ≤ 5.00x Captured at test | Pass |
| BluePeak Healthcare Solutions Q3 2026 | Interest Coverage Supplied actual | 1.61x | ≥ 1.40x Captured at test | Pass |
| BluePeak Healthcare Solutions Q3 2026 | Minimum LTM EBITDA ($M) Supplied actual | $22.5M | ≥ $21.0M Captured at test | Tight |